RACHEL APPOO: Open Payments
NPI 1700384948 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,707 in 67 payments from 25 companies in 2025. Trend: 2023 $582 · 2024 $1,688 · 2025 $2,707
Food & beverage: $2,707
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 4 | $453 |
| COLOPLAST CORP | 17 | $327 |
| ABIOMED | 2 | $229 |
| Sumitomo Pharma America, Inc. | 10 | $203 |
| Teleflex LLC | 5 | $186 |
| AstraZeneca Pharmaceuticals LP | 1 | $132 |
| Gilead Sciences, Inc. | 1 | $130 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $120 |
| Axsome Therapeutics, Inc. | 1 | $117 |
Products named: SYMPLICITY G3, Luja Coude, GEMTESA, BARRIGEL, INTERSTIM, BREZTRI, Epclusa, INGREZZA.
Industry payments across FL — which companies pay providers there.
